首页 > 最新文献

Journal of Holistic Integrative Pharmacy最新文献

英文 中文
Vitamins strategies for psoriasis: An update on current scientific evidence
Pub Date : 2023-12-01 DOI: 10.1016/j.jhip.2024.01.005
Suyash Agnihotri , Jasleen Kaur , Priya Masand , Anurag , Vipan Kumar Parihar , Alok Sharma
Psoriasis is an aggressive chronic skin disorder that requires various therapies such as topical, oral, and occasionally, subcutaneous, or intravenous. In contrast, vitamins have more significant evidence in alteration to first-line therapies in the treatment of psoriasis. Vitamins such as fat-soluble and water-soluble supplements act as a secondary treatment that is given to reduce possible adverse effects from systematic medication, increase patient compliance, and consider affordable treatment costs. Here, the comparative study was conducted based on the data search from Pub Med, Google Scholar, Willy Library, etc., for both fat and water-soluble vitamins in psoriasis treatment first time. The present review summarizes the role of fat-soluble vitamins (A, D, E) and water-soluble vitamins (B2, B6, B12, and C) based therapies in psoriasis treatment and result highlights the efficiency of oral supplementation of vitamins in psoriasis and systematic inflammation. Further, clinical studies along with in-vitro and in vivo based investigations have been compiled in this review, which shows that vitamins effectively can manage psoriasis. Additionally, the present review consists of chemical identification of both fat and water-soluble vitamins by High Performance Liquid Chromatography. The role of vitamins therapies in psoriasis management is promising and can be further to give in new horizon for improving the treatment efficacy. This review could provide an insight into vitamins emerging therapy in the treatments of psoriasis.
{"title":"Vitamins strategies for psoriasis: An update on current scientific evidence","authors":"Suyash Agnihotri ,&nbsp;Jasleen Kaur ,&nbsp;Priya Masand ,&nbsp;Anurag ,&nbsp;Vipan Kumar Parihar ,&nbsp;Alok Sharma","doi":"10.1016/j.jhip.2024.01.005","DOIUrl":"10.1016/j.jhip.2024.01.005","url":null,"abstract":"<div><div>Psoriasis is an aggressive chronic skin disorder that requires various therapies such as topical, oral, and occasionally, subcutaneous, or intravenous. In contrast, vitamins have more significant evidence in alteration to first-line therapies in the treatment of psoriasis. Vitamins such as fat-soluble and water-soluble supplements act as a secondary treatment that is given to reduce possible adverse effects from systematic medication, increase patient compliance, and consider affordable treatment costs. Here, the comparative study was conducted based on the data search from Pub Med, Google Scholar, Willy Library, etc., for both fat and water-soluble vitamins in psoriasis treatment first time. The present review summarizes the role of fat-soluble vitamins (A, D, E) and water-soluble vitamins (B<sub>2</sub>, B<sub>6</sub>, B<sub>12</sub>, and C) based therapies in psoriasis treatment and result highlights the efficiency of oral supplementation of vitamins in psoriasis and systematic inflammation. Further, clinical studies along with <em>in-vitro</em> and <em>in vivo</em> based investigations have been compiled in this review, which shows that vitamins effectively can manage psoriasis. Additionally, the present review consists of chemical identification of both fat and water-soluble vitamins by High Performance Liquid Chromatography. The role of vitamins therapies in psoriasis management is promising and can be further to give in new horizon for improving the treatment efficacy. This review could provide an insight into vitamins emerging therapy in the treatments of psoriasis.</div></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"4 4","pages":"Pages 299-309"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143291715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identifying candidate drugs based on transcriptional landscape associated with triple-negative breast cancer
Pub Date : 2023-12-01 DOI: 10.1016/j.jhip.2023.12.001
Yuqin Lin , Yanghong Zhu , Xiang Li , Qi Chen , Guoyu Wu
Triple-negative breast cancer (TNBC) is a special type of breast cancer in which ER, PR and HER2 are all negative, characterized by high malignancy, strong invasiveness, and high recurrence rate. It is critical to develop novel drugs for improved therapies for triple-negative breast cancers. Here, we unveiled the transcriptional landscape associated with triple-negative breast cancer and identified candidate drugs using a comprehensive connectivity map. The candidate components could induce reverse expressions of the TNBC gene expression signature and trigger transcriptional reprogramming with a positive impact on modulating chemoresistance and the survival probability of breast cancer patients. Our study also provided an example of drug discovery using in silico drug screening followed by further validations, illustrating an effective computational drug discovery strategy.
{"title":"Identifying candidate drugs based on transcriptional landscape associated with triple-negative breast cancer","authors":"Yuqin Lin ,&nbsp;Yanghong Zhu ,&nbsp;Xiang Li ,&nbsp;Qi Chen ,&nbsp;Guoyu Wu","doi":"10.1016/j.jhip.2023.12.001","DOIUrl":"10.1016/j.jhip.2023.12.001","url":null,"abstract":"<div><div>Triple-negative breast cancer (TNBC) is a special type of breast cancer in which ER, PR and HER2 are all negative, characterized by high malignancy, strong invasiveness, and high recurrence rate. It is critical to develop novel drugs for improved therapies for triple-negative breast cancers. Here, we unveiled the transcriptional landscape associated with triple-negative breast cancer and identified candidate drugs using a comprehensive connectivity map. The candidate components could induce reverse expressions of the TNBC gene expression signature and trigger transcriptional reprogramming with a positive impact on modulating chemoresistance and the survival probability of breast cancer patients. Our study also provided an example of drug discovery using <em>in silico</em> drug screening followed by further validations, illustrating an effective computational drug discovery strategy.</div></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"4 4","pages":"Pages 318-324"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143291716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the therapeutic effects of Zingiberis Rhizoma Preparatum (Pao-Jiang) against DSS-induced ulcerative colitis in mice by metabolomics-guided analysis
Pub Date : 2023-12-01 DOI: 10.1016/j.jhip.2024.01.001
Jianliang Geng , Chen Chen , Dabo Pan , Qiuhong Wang
Zingiberis Rhizoma Recens (Sheng-Jiang) is a kind of edible and medicinal plant resource in China. Both Zingiberis Rhizoma Recens and its dried form, Zingiberis Rhizome (Gan-Jiang), have been widely used in traditional Chinese medicine prescriptions for the treatment of digestive disease. Based on traditional Chinese medicine (TCM) theory, the heat-processed product of Zingiberis Rhizome, Zingiberis Rhizoma Preparatum (Pao-Jiang) is more effective in arresting bleeding and alleviating pain, which is suitable for relieving the classic symptoms of ulcerative colitis (UC), a chronic relapsing idiopathic inflammation of the gastrointestinal tract. In present study, the pharmacological evaluation combined with metabolomics-guided analysis were applied to explore the intestinal protective effects and mechanism of Pao-Jiang on dextran sulfate sodium (DSS)-induced colitis mouse model. The pathological and biochemical tests showed that the water and alcohol extracts of Gan-Jiang and Pao-Jiang could reduce the disease activity index (DAI) and colon tissue damage, inhibit the secretion of pro-inflammatory cytokines tumor necrosis factor-α (TNF-α) and leukocyte-mediated interleukin-1β and 6 (IL-1β and IL-6), and alleviate abnormal histopathological changes of UC mice in various degrees. The alcohol extracts of Pao-Jiang showed relatively better effects. Untargeted and targeted metabolomic profiling revealed that the alcohol extracts of Pao-Jiang can significantly reverse the UC induced metabolic perturbations, especially focuses on bile acids metabolism, eicosanoids and phospholipids metabolism. Furthermore, comparative chemical profiling and molecular docking analysis indicated that the contents of shogaols and gingerdiones in Pao-Jiang increased after heating processing and may contribute to the regulatory effects of bile acid synthesis and transport by interacting with CYP7A1, BSEP and IBABP, and promote the anti-inflammatory effects. This study expands our knowledge about potential function of Gan-Jiang and Pao-Jiang, and are of significance for providing insights into the scientific connotation of traditional Chinese medicine processing methods.
{"title":"Exploring the therapeutic effects of Zingiberis Rhizoma Preparatum (Pao-Jiang) against DSS-induced ulcerative colitis in mice by metabolomics-guided analysis","authors":"Jianliang Geng ,&nbsp;Chen Chen ,&nbsp;Dabo Pan ,&nbsp;Qiuhong Wang","doi":"10.1016/j.jhip.2024.01.001","DOIUrl":"10.1016/j.jhip.2024.01.001","url":null,"abstract":"<div><div>Zingiberis Rhizoma Recens (Sheng-Jiang) is a kind of edible and medicinal plant resource in China. Both Zingiberis Rhizoma Recens and its dried form, Zingiberis Rhizome (Gan-Jiang), have been widely used in traditional Chinese medicine prescriptions for the treatment of digestive disease. Based on traditional Chinese medicine (TCM) theory, the heat-processed product of Zingiberis Rhizome, Zingiberis Rhizoma Preparatum (Pao-Jiang) is more effective in arresting bleeding and alleviating pain, which is suitable for relieving the classic symptoms of ulcerative colitis (UC), a chronic relapsing idiopathic inflammation of the gastrointestinal tract. In present study, the pharmacological evaluation combined with metabolomics-guided analysis were applied to explore the intestinal protective effects and mechanism of Pao-Jiang on dextran sulfate sodium (DSS)-induced colitis mouse model. The pathological and biochemical tests showed that the water and alcohol extracts of Gan-Jiang and Pao-Jiang could reduce the disease activity index (DAI) and colon tissue damage, inhibit the secretion of pro-inflammatory cytokines tumor necrosis factor-α (TNF-α) and leukocyte-mediated interleukin-1β and 6 (IL-1β and IL-6), and alleviate abnormal histopathological changes of UC mice in various degrees. The alcohol extracts of Pao-Jiang showed relatively better effects. Untargeted and targeted metabolomic profiling revealed that the alcohol extracts of Pao-Jiang can significantly reverse the UC induced metabolic perturbations, especially focuses on bile acids metabolism, eicosanoids and phospholipids metabolism. Furthermore, comparative chemical profiling and molecular docking analysis indicated that the contents of shogaols and gingerdiones in Pao-Jiang increased after heating processing and may contribute to the regulatory effects of bile acid synthesis and transport by interacting with CYP7A1, BSEP and IBABP, and promote the anti-inflammatory effects. This study expands our knowledge about potential function of Gan-Jiang and Pao-Jiang, and are of significance for providing insights into the scientific connotation of traditional Chinese medicine processing methods.</div></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"4 4","pages":"Pages 272-280"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143291709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological project (SMART-PT) for transparency and methodological characteristics of randomized controlled trials of phytotherapy interventions
Pub Date : 2023-12-01 DOI: 10.1016/j.jhip.2024.01.004
Cuncun Lu , Xiuxiu Deng , Ziyi Wang , Xiaoxiao Zhao , Lixin Ke , Zhifei Wang

Background

Randomized controlled trials (RCTs) are the gold standard for evaluating the efficacy and safety of medical interventions. Phytotherapy, which plays a critical role in the prevention and treatment of many clinical conditions, is also evaluated by RCTs. In recent years, the transparency, methodology, and generalizability of RCTs, as well as disparities in gender and geographical location among researchers, have attracted much attention from the scientific community. However, these aspects of RCTs in phytotherapy interventions have not been fully evaluated. Therefore, a methodological project (i.e., SMART-PT, tranSparency and Methodological chAracteristics of Randomized controlled Trials of PhytoTherapy interventions) was designed to overcome these knowledge gaps and provide key references for relevant future RCTs.

Methods

The SMART-PT project consists of five studies that will be conducted using RCTs derived from two high-impact phytotherapy journals, Phytomedicine and Phytotherapy Research. RCTs published in Phytomedicine and Phytotherapy Research were searched using the PubMed database from inception to February 13, 2023. Study selection was performed by two independent researchers, and data extraction and quality assessment will also be conducted independently by two researchers. First, we will investigate the reporting completeness, data-sharing level, and presence of spin among the included RCTs (Study 1). Second, we will evaluate the risk of bias in the included RCTs and the statistical fragility of primarily binary outcomes, and the likelihood ratio will be used to reinterpret statistically nonsignificant primary outcomes (Study 2). Third, we will evaluate the reporting completeness of phytotherapy interventions in the included RCTs as well as the trustworthiness of the RCTs (Study 3). Fourth, we will investigate the reporting of sociodemographic features and representation of participants in the included RCTs (Study 4). Finally, we will investigate the reporting completeness of the abstracts, the representation of gender, and geographical region of the listed authors among the included RCTs (Study 5). R 4.2.3, Stata 17/SE, and Excel 2019 will be used to analyze the data and create graphics.

Results and Discussion

One-hundred and fifty-two double-arm, parallel-group, superiority RCTs were included in the SMART-PT project. The results of the five meta-research studies will be submitted for publication in peer-reviewed journals.
{"title":"Methodological project (SMART-PT) for transparency and methodological characteristics of randomized controlled trials of phytotherapy interventions","authors":"Cuncun Lu ,&nbsp;Xiuxiu Deng ,&nbsp;Ziyi Wang ,&nbsp;Xiaoxiao Zhao ,&nbsp;Lixin Ke ,&nbsp;Zhifei Wang","doi":"10.1016/j.jhip.2024.01.004","DOIUrl":"10.1016/j.jhip.2024.01.004","url":null,"abstract":"<div><h3>Background</h3><div>Randomized controlled trials (RCTs) are the gold standard for evaluating the efficacy and safety of medical interventions. Phytotherapy, which plays a critical role in the prevention and treatment of many clinical conditions, is also evaluated by RCTs. In recent years, the transparency, methodology, and generalizability of RCTs, as well as disparities in gender and geographical location among researchers, have attracted much attention from the scientific community. However, these aspects of RCTs in phytotherapy interventions have not been fully evaluated. Therefore, a methodological project (i.e., SMART-PT, tranSparency and Methodological chAracteristics of Randomized controlled Trials of PhytoTherapy interventions) was designed to overcome these knowledge gaps and provide key references for relevant future RCTs.</div></div><div><h3>Methods</h3><div>The SMART-PT project consists of five studies that will be conducted using RCTs derived from two high-impact phytotherapy journals, <em>Phytomedicine</em> and <em>Phytotherapy Research</em>. RCTs published in <em>Phytomedicine</em> and <em>Phytotherapy Research</em> were searched using the PubMed database from inception to February 13, 2023. Study selection was performed by two independent researchers, and data extraction and quality assessment will also be conducted independently by two researchers. First, we will investigate the reporting completeness, data-sharing level, and presence of spin among the included RCTs (Study 1). Second, we will evaluate the risk of bias in the included RCTs and the statistical fragility of primarily binary outcomes, and the likelihood ratio will be used to reinterpret statistically nonsignificant primary outcomes (Study 2). Third, we will evaluate the reporting completeness of phytotherapy interventions in the included RCTs as well as the trustworthiness of the RCTs (Study 3). Fourth, we will investigate the reporting of sociodemographic features and representation of participants in the included RCTs (Study 4). Finally, we will investigate the reporting completeness of the abstracts, the representation of gender, and geographical region of the listed authors among the included RCTs (Study 5). R 4.2.3, Stata 17/SE, and Excel 2019 will be used to analyze the data and create graphics.</div></div><div><h3>Results and Discussion</h3><div>One-hundred and fifty-two double-arm, parallel-group, superiority RCTs were included in the SMART-PT project. The results of the five meta-research studies will be submitted for publication in peer-reviewed journals.</div></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"4 4","pages":"Pages 293-298"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143291710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis, cytotoxicity study of novel bisacridine derivatives and their interaction with c-myc promoter G-quadruplex/i-motif
Pub Date : 2023-12-01 DOI: 10.1016/j.jhip.2024.01.003
Bing Shu , Wang-liang Chen , Jia-lin Song , Shen Fang , Jiong-bang Li , Shang-shi Zhang

Objective

To synthesize novel bisacridine derivatives A1-A4 and study cytotoxicity and their interaction with c-myc G-quadruplex/i-motif DNA.

Method

Bisacridines A1-A4 were synthesized according to the conventional reaction method. Fluorescence resonance energy transfer (FRET) melting assay, Surface Plasmon Resonance (SPR) measurement, CD experiments, and molecular docking were used to study the interactions between A1-A4 and c-myc promoter G-quadruplex/i-motif. MTT cytotoxicity assay was used to evaluate the cytotoxicity of the bisacridine derivatives A1-A4 against A375, Hela, A549, U2OS, HCT116, Siha, HuH7 cell lines.

Result

The results of FRET melting assay and SPR measurement indicated that bisacridine derivatives A1-A4 could bind to and stabilize the c-myc G-quadruplex/i-motif structure. CD experiments and molecular docking results demonstrated the interaction between A1-A4 and c-myc G-quadruplex/i-motif. MTT experiments showed that A1-A4 exhibited strong inhibitory effects on the proliferation of human A375, Hela, A549, U2OS, HCT116, Siha, HuH7 cell lines.

Conclusion

Bisacridine derivatives A1-A4 could bind to and stabilize the c-myc G-quadruplex/i-motif to inhibit the proliferation of human cancer cells and will potentially be developed into a class of small molecule ligands targeting c-myc G-quadruplex/i-motif.
{"title":"Synthesis, cytotoxicity study of novel bisacridine derivatives and their interaction with c-myc promoter G-quadruplex/i-motif","authors":"Bing Shu ,&nbsp;Wang-liang Chen ,&nbsp;Jia-lin Song ,&nbsp;Shen Fang ,&nbsp;Jiong-bang Li ,&nbsp;Shang-shi Zhang","doi":"10.1016/j.jhip.2024.01.003","DOIUrl":"10.1016/j.jhip.2024.01.003","url":null,"abstract":"<div><h3>Objective</h3><div>To synthesize novel bisacridine derivatives <strong>A1</strong>-<strong>A4</strong> and study cytotoxicity and their interaction with <em>c-myc</em> G-quadruplex/i-motif DNA.</div></div><div><h3>Method</h3><div>Bisacridines <strong>A1</strong>-<strong>A4</strong> were synthesized according to the conventional reaction method. Fluorescence resonance energy transfer (FRET) melting assay, Surface Plasmon Resonance (SPR) measurement, CD experiments, and molecular docking were used to study the interactions between <strong>A1</strong>-<strong>A4</strong> and <em>c-myc</em> promoter G-quadruplex/i-motif. MTT cytotoxicity assay was used to evaluate the cytotoxicity of the bisacridine derivatives <strong>A1-A4</strong> against A375, Hela, A549, U2OS, HCT116, Siha, HuH7 cell lines.</div></div><div><h3>Result</h3><div>The results of FRET melting assay and SPR measurement indicated that bisacridine derivatives <strong>A1-A4</strong> could bind to and stabilize the <em>c-myc</em> G-quadruplex/i-motif structure. CD experiments and molecular docking results demonstrated the interaction between <strong>A1-A4</strong> and <em>c-myc</em> G-quadruplex/i-motif. MTT experiments showed that <strong>A1-A4</strong> exhibited strong inhibitory effects on the proliferation of human A375, Hela, A549, U2OS, HCT116, Siha, HuH7 cell lines.</div></div><div><h3>Conclusion</h3><div>Bisacridine derivatives <strong>A1-A4</strong> could bind to and stabilize the <em>c-myc</em> G-quadruplex/i-motif to inhibit the proliferation of human cancer cells and will potentially be developed into a class of small molecule ligands targeting <em>c-myc</em> G-quadruplex/i-motif.</div></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"4 4","pages":"Pages 281-286"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143291712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chloroplast genome of Thesium chinense: The insight into phylogeny of Santalaceae
Pub Date : 2023-12-01 DOI: 10.1016/j.jhip.2024.01.007
Zhenyu Zhao , Hongxiu Li , Meilan Chen , Meng Cheng , Cadiz Quispe Gustavo Pedro , Xiuteng Zhou , Luqi Huang
Thesium chinense is an important and commonly used traditional Chinese medicine. The aim of this study is to obtain more bioinformatics from Thesium chinense and to conduct a more comprehensive and in-depth analysis of Santalaceae's phylogeny. This study sequenced the chloroplast genome of Thesium chinense and performed bioinformatics analysis on its key genes to reconstruct the Santalaceae phylogenetic tree. The genes of traditional Chinese medicine often affect the generation and accumulation of metabolic products. The different genes in the chloroplast genome of Thesium chinense have different biological characteristics. The phylogenetic system of Santalaceae and its related families differs significantly from classical classification. This study has laid a solid foundation for the better application and identification of Thesium chinense.
{"title":"Chloroplast genome of Thesium chinense: The insight into phylogeny of Santalaceae","authors":"Zhenyu Zhao ,&nbsp;Hongxiu Li ,&nbsp;Meilan Chen ,&nbsp;Meng Cheng ,&nbsp;Cadiz Quispe Gustavo Pedro ,&nbsp;Xiuteng Zhou ,&nbsp;Luqi Huang","doi":"10.1016/j.jhip.2024.01.007","DOIUrl":"10.1016/j.jhip.2024.01.007","url":null,"abstract":"<div><div><em>Thesium chinense</em> is an important and commonly used traditional Chinese medicine. The aim of this study is to obtain more bioinformatics from <em>Thesium chinense</em> and to conduct a more comprehensive and in-depth analysis of Santalaceae's phylogeny. This study sequenced the chloroplast genome of <em>Thesium chinense</em> and performed bioinformatics analysis on its key genes to reconstruct the Santalaceae phylogenetic tree. The genes of traditional Chinese medicine often affect the generation and accumulation of metabolic products. The different genes in the chloroplast genome of <em>Thesium chinense</em> have different biological characteristics. The phylogenetic system of Santalaceae and its related families differs significantly from classical classification. This study has laid a solid foundation for the better application and identification of <em>Thesium chinense</em>.</div></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"4 4","pages":"Pages 310-317"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143291717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The critical role of signal transducers and activators of transcription-3 in the proliferation of vascular smooth muscle cells 信号转导和转录激活因子-3 在血管平滑肌细胞增殖中的关键作用
Pub Date : 2023-11-01 DOI: 10.1016/j.jhip.2023.11.007
Shuai Li, Chan Liu

The proliferation of vascular smooth muscle cells (VSMCs) is a key pathogenic characteristic of vascular remodeling diseases. The signal transducers and activators of transcription-3 (STAT3) signaling pathway is crucial for VSMCs growth, and its role in cytokine-induced VSMCs proliferation, calcification, and phenotypic switching is essential for developing new treatment targets. VSMCs can transform from contractile to synthetic phenotypes in response to stimuli, such as mechanical forces, growth factors, pro-inflammatory cytokines, and vascular injury. Understanding the mechanism of VSMCs proliferation triggered by the STAT3 pathway is important for identifying potential therapeutic targets for vascular remodeling diseases.

血管平滑肌细胞(VSMCs)的增殖是血管重构疾病的一个重要致病特征。转录-3信号通路的信号转导和激活因子(STAT3)对VSMCs的生长至关重要,其在细胞因子诱导的VSMCs增殖、钙化和表型转换中的作用对于开发新的治疗靶点至关重要。VSMCs可以在机械力、生长因子、促炎细胞因子和血管损伤等刺激下从收缩型转变为合成型。了解STAT3通路触发VSMCs增殖的机制对于确定血管重塑疾病的潜在治疗靶点具有重要意义。
{"title":"The critical role of signal transducers and activators of transcription-3 in the proliferation of vascular smooth muscle cells","authors":"Shuai Li,&nbsp;Chan Liu","doi":"10.1016/j.jhip.2023.11.007","DOIUrl":"https://doi.org/10.1016/j.jhip.2023.11.007","url":null,"abstract":"<div><p>The proliferation of vascular smooth muscle cells (VSMCs) is a key pathogenic characteristic of vascular remodeling diseases. The signal transducers and activators of transcription-3 (STAT3) signaling pathway is crucial for VSMCs growth, and its role in cytokine-induced VSMCs proliferation, calcification, and phenotypic switching is essential for developing new treatment targets. VSMCs can transform from contractile to synthetic phenotypes in response to stimuli, such as mechanical forces, growth factors, pro-inflammatory cytokines, and vascular injury. Understanding the mechanism of VSMCs proliferation triggered by the STAT3 pathway is important for identifying potential therapeutic targets for vascular remodeling diseases.</p></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"4 3","pages":"Pages 241-247"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2707368823001127/pdfft?md5=bfc9f9ce462b4256522d58bda558f653&pid=1-s2.0-S2707368823001127-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138678494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study on the synergistic development of TCM service trade within the GBA 全球中医药服务贸易协同发展研究
Pub Date : 2023-11-01 DOI: 10.1016/j.jhip.2023.12.002
Qiu Zhang , Chuyun Wu , Xinrong Ai , Mandong Huang , Baifeng Zheng , Yiling Li , Shuli Zhang , Liqing Yao , Jiangyue Wang , Yingying Tang

Objectives

This study analyzed the synergistic development of the Traditional Chinese Medicine (TCM) service trade within the Greater Bay Area (GBA) in China, aiming to provide suggestions and references for the development of TCM service trade around the world.

Methods

Taking the typical and representative Guangdong, Hong Kong and Macao Greater Bay Area as the research object, this paper focused on four modes of “cross-border supply, offshore consumption, commercial presence, and movement of natural persons”, and explored the current situation of TCM service trade from four macroscopic aspects: political, economic, social, and technological, through case studies. The challenges in the development of TCM service trade were analyzed.

Results

Our study found that the degree of synergistic openness of Guangdong, Hong Kong and Macao needs to be improved. The integration of trade in TCM services is the integration of TCM services with tourism. However, there is a relative lack of human resources in TCM in Hong Kong and Macao, with weak competitiveness of service bases. The resources of TCM services are still under-utilized, and the GBA market of TCM services lacks momentum.

Conclusions

We have come to the conclusion that the GBA need to promptly improve the unified standard system of TCM service trade. Actively building cultivating a “Bay Area GBA brand” for TCM service trade, steadily building a social climate in support of TCM service trade and vigorously promote the development of TCM service trade through digital technology, thus promoting the synergistic development of TCM service trade within the GBA.

目的本研究分析了中国粤港澳大湾区内中医药服务贸易的协同发展情况,旨在为全球中医药服务贸易的发展提供建议和参考。方法本文以具有典型性和代表性的粤港澳大湾区为研究对象,围绕 "跨境供给、离岸消费、商业存在、自然人流动 "四种模式,通过案例分析,从政治、经济、社会、技术四个宏观方面探讨了中医药服务贸易的现状。研究发现,粤港澳三地的协同开放程度有待提高。中医药服务贸易的融合就是中医药服务与旅游业的融合。但港澳中医药人力资源相对缺乏,服务基地竞争力不强。中医药服务资源仍未得到充分利用,粤港澳大湾区中医药服务市场缺乏发展动力。积极打造中医药服务贸易 "粤港澳大湾区品牌",稳步营造支持中医药服务贸易的社会氛围,通过数字技术大力推动中医药服务贸易的发展,从而促进粤港澳大湾区中医药服务贸易的协同发展。
{"title":"Study on the synergistic development of TCM service trade within the GBA","authors":"Qiu Zhang ,&nbsp;Chuyun Wu ,&nbsp;Xinrong Ai ,&nbsp;Mandong Huang ,&nbsp;Baifeng Zheng ,&nbsp;Yiling Li ,&nbsp;Shuli Zhang ,&nbsp;Liqing Yao ,&nbsp;Jiangyue Wang ,&nbsp;Yingying Tang","doi":"10.1016/j.jhip.2023.12.002","DOIUrl":"https://doi.org/10.1016/j.jhip.2023.12.002","url":null,"abstract":"<div><h3>Objectives</h3><p>This study analyzed the synergistic development of the Traditional Chinese Medicine (TCM) service trade within the Greater Bay Area (GBA) in China, aiming to provide suggestions and references for the development of TCM service trade around the world.</p></div><div><h3>Methods</h3><p>Taking the typical and representative Guangdong, Hong Kong and Macao Greater Bay Area as the research object, this paper focused on four modes of “cross-border supply, offshore consumption, commercial presence, and movement of natural persons”, and explored the current situation of TCM service trade from four macroscopic aspects: political, economic, social, and technological, through case studies. The challenges in the development of TCM service trade were analyzed.</p></div><div><h3>Results</h3><p>Our study found that the degree of synergistic openness of Guangdong, Hong Kong and Macao needs to be improved. The integration of trade in TCM services is the integration of TCM services with tourism. However, there is a relative lack of human resources in TCM in Hong Kong and Macao, with weak competitiveness of service bases. The resources of TCM services are still under-utilized, and the GBA market of TCM services lacks momentum.</p></div><div><h3>Conclusions</h3><p>We have come to the conclusion that the GBA need to promptly improve the unified standard system of TCM service trade. Actively building cultivating a “Bay Area GBA brand” for TCM service trade, steadily building a social climate in support of TCM service trade and vigorously promote the development of TCM service trade through digital technology, thus promoting the synergistic development of TCM service trade within the GBA.</p></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"4 3","pages":"Pages 248-255"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2707368823001140/pdfft?md5=25f217c222d74b1c328c35ef0bcf005e&pid=1-s2.0-S2707368823001140-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139099697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dioscoreae persimilis polysaccharide ameliorates DSS-induced ulcerative colitis in mice through modulation of microbiota composition 薯蓣多糖通过调节微生物群组成改善dss诱导的小鼠溃疡性结肠炎
Pub Date : 2023-11-01 DOI: 10.1016/j.jhip.2023.09.004
Qian Zhang , Guorong Wu , Shumin Shen , Chong Li

Ulcerative colitis (UC) is a non-specific inflammatory bowel disease that has a high rate of recurrence, development of novel therapeutic approaches with high efficacy and few adverse effects are still needed. Dioscoreae persimilis is an edible plant that has been widely consumed as a remedy for gastrointestinal diseases in traditional Chinese medicine. Polysaccharides have been proven to have protective effects on UC. However, the role of polysaccharides from D. persimilis in UC has not been studied yet. The refined D. persimilis Polysaccharide (DP), which consists of glucose and galactose, was extracted and purified using three-phase partitioning (TPP) method. The primary chemical and structural characteristics of DP were investigated by UV, FT-IR, molecular weight, and monosaccharide composition. Based on dextran sulfate sodium (DSS) induced UC in mice, the alleviatory effect of DP on UC was explored. DP was found to alleviate histopathological changes of colon, improve colonic antioxidant capacity and ameliorate inflammation response in colitis mice. Moreover, 16S rDNA sequencing of fecal revealed that DP could restore the diversity and composition of gut microbiota, especially up-regulates the abundance of Acetatifactor, Lachnospiraceae, and Lactobacillus, and increase the ratio of Firmicutes/Bacteroidetes. According to this study, DP has the potential to serve as an effective nutritional supplement for improving colitis.

溃疡性结肠炎(UC)是一种复发率高的非特异性炎症性肠病,目前仍需要开发高效、不良反应少的新型治疗方法。薯蓣(Dioscoreae persimilis)是一种可食用的植物,在中医中被广泛用作治疗胃肠道疾病的药物。多糖已被证明对UC有保护作用。然而,紫苏多糖在UC中的作用尚未得到研究。采用三相分割(TPP)法提取和纯化了由葡萄糖和半乳糖组成的紫苏多糖(DP)。通过紫外光谱、红外光谱、分子量、单糖组成等研究了DP的主要化学性质和结构特征。以葡聚糖硫酸钠(DSS)致小鼠UC为实验对象,探讨DP对UC的缓解作用。研究发现,DP可减轻结肠炎小鼠结肠组织病理改变,提高结肠抗氧化能力,改善炎症反应。此外,粪便的16S rDNA测序结果显示,DP可以恢复肠道菌群的多样性和组成,特别是提高乙酰化因子(Acetatifactor)、毛螺科(Lachnospiraceae)和乳酸杆菌(Lactobacillus)的丰度,提高厚壁菌门(Firmicutes) /拟杆菌门(Bacteroidetes)的比例。根据这项研究,DP有可能作为一种有效的营养补充剂来改善结肠炎。
{"title":"Dioscoreae persimilis polysaccharide ameliorates DSS-induced ulcerative colitis in mice through modulation of microbiota composition","authors":"Qian Zhang ,&nbsp;Guorong Wu ,&nbsp;Shumin Shen ,&nbsp;Chong Li","doi":"10.1016/j.jhip.2023.09.004","DOIUrl":"https://doi.org/10.1016/j.jhip.2023.09.004","url":null,"abstract":"<div><p>Ulcerative colitis (UC) is a non-specific inflammatory bowel disease that has a high rate of recurrence, development of novel therapeutic approaches with high efficacy and few adverse effects are still needed. <em>Dioscoreae persimilis</em> is an edible plant that has been widely consumed as a remedy for gastrointestinal diseases in traditional Chinese medicine. Polysaccharides have been proven to have protective effects on UC. However, the role of polysaccharides from <em>D. persimilis</em> in UC has not been studied yet. The refined <em>D. persimilis</em> Polysaccharide (DP), which consists of glucose and galactose, was extracted and purified using three-phase partitioning (TPP) method. The primary chemical and structural characteristics of DP were investigated by UV, FT-IR, molecular weight, and monosaccharide composition. Based on dextran sulfate sodium (DSS) induced UC in mice, the alleviatory effect of DP on UC was explored. DP was found to alleviate histopathological changes of colon, improve colonic antioxidant capacity and ameliorate inflammation response in colitis mice. Moreover, 16S rDNA sequencing of fecal revealed that DP could restore the diversity and composition of gut microbiota, especially up-regulates the abundance of <em>Acetatifactor</em>, <em>Lachnospiraceae</em>, and <em>Lactobacillus</em>, and increase the ratio of Firmicutes/Bacteroidetes. According to this study, DP has the potential to serve as an effective nutritional supplement for improving colitis.</p></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"4 2","pages":"Pages 157-165"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2707368823000870/pdfft?md5=3449395a1f245bdf9f5916c92cf00ed6&pid=1-s2.0-S2707368823000870-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92047740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tianhuang formula ameliorates non-alcoholic fatty liver diseases in type 2 diabetic mice through CRLS1-ATF3/ChREBP pathway 天黄方通过CRLS1-ATF3/ChREBP通路改善2型糖尿病小鼠非酒精性脂肪肝
Pub Date : 2023-11-01 DOI: 10.1016/j.jhip.2023.09.002
Yi Han , Yating Zhao , Xuefeng Xu , Zhizhong Luo , Duosheng Luo , Jiao Guo

Objective

Tianhuang Formula (THF) is a hospital formula summarized by Professor Jiao Guo's 30 years of clinical experience. Some studies have shown that it can alleviate dyslipidemia in the body. The purpose of this study is to confirm whether THF can improve non-alcoholic fatty liver diseases (NAFLD) in type 2 diabetic mice induced by high-fat diet (HFD)/streptomycin (STZ) and to clarify its potential mechanism.

Methods

After induction of diabetes, mice were administrated with THF (60 ​mg/kg or 120 ​mg/kg) once daily for 10 weeks. Blood glucose (FBG), glucose tolerance, and insulin resistance (IR) were assayed by oral glucose tolerance test (OGTT) and insulin tolerance test (ITT). Blood lipids, alanine transaminase (ALT), and aspartate transaminases (AST) were detected. Serum fasting insulin (INS) and adiponectin (APN) levels were measured using ELISA. Histological changes in liver and pancreatic islets were observed by H&E staining, followed by Oil Red O staining for liver lipid quantification and periodic acid-Schiff (PAS) staining to detect glycogen accumulation. Western blotting detected the levels of fatty cardiolipin synthase 1 (CRLS1), transcription factor activator 3 (ATF3), and carbohydrate-responsive element binding protein (ChREBP) in the liver. The mRNA transcripts of hepatic inflammatory factors, lipogenesis and lipolysis-related genes, and gluconeogenic enzyme-phosphoenolpyruvate carboxykinase (PEPCK), CRLS1, ATF3, and ChREBP mRNA levels were evaluated by RT-qPCR.

Results

THF restored impaired glucose tolerance and insulin resistance, respectively. There was an improvement in HFD/STZ-induced liver and islet damage, high serum HDL-C and ANP levels, and a significant decrease in FBG, total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), FFA, INS, ALT, and AST, and lipid droplet counts in the T2DM mice treated with THF. CREBBP binding protein ATF3 mediated the insulin resistance signaling pathway, which regulated glucose and lipid metabolism in the liver. THF upregulated CRLS1, and ChREBP downregulated the expression of downstream ATF3 in the liver. RT-qPCR analysis also systemically indicated that THF suppressed the pathway and key regulators related to inflammation, lipid accumulation, and gluconeogenesis.

Conclusion

Our findings demonstrated that THF ameliorated lipid profile and attenuated liver steatosis in T2DM mice through CRLS1-ATF3/ChREBP pathway activation.

目的:天黄方是焦果教授根据30多年临床经验总结的医院方。一些研究表明,它可以缓解体内的血脂异常。本研究的目的是证实THF是否可以改善高脂饮食(HFD)/链霉素(STZ)诱导的2型糖尿病小鼠的非酒精性脂肪性肝病(NAFLD),并阐明其潜在机制。方法小鼠诱导糖尿病后,每天1次给予四氢呋嗪(60 mg/kg或120 mg/kg),连续10周。采用口服葡萄糖耐量试验(OGTT)和胰岛素耐量试验(ITT)测定血糖(FBG)、葡萄糖耐量和胰岛素抵抗(IR)。检测血脂、谷丙转氨酶(ALT)、天冬氨酸转氨酶(AST)。采用ELISA法测定血清空腹胰岛素(INS)和脂联素(APN)水平。采用H&E染色观察肝脏和胰岛的组织学变化,油红O染色定量肝脂质,周期性酸-希夫(PAS)染色检测糖原积累。Western blotting检测肝脏中脂肪性心磷脂合成酶1 (CRLS1)、转录因子激活因子3 (ATF3)和碳水化合物反应元件结合蛋白(ChREBP)的水平。RT-qPCR检测肝脏炎症因子、脂肪生成和脂解相关基因、糖异生酶-磷酸烯醇丙酮酸羧激酶(PEPCK)、CRLS1、ATF3和ChREBP mRNA表达水平。结果四氢呋嗪可分别恢复糖耐量和胰岛素抵抗。经THF治疗的T2DM小鼠的FBG、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、FFA、INS、ALT、AST和脂滴计数显著降低,HFD/ stz诱导的肝脏和胰岛损伤得到改善。CREBBP结合蛋白ATF3介导胰岛素抵抗信号通路,调节肝脏糖脂代谢。THF上调CRLS1, ChREBP下调肝脏下游ATF3的表达。RT-qPCR分析也系统地表明,THF抑制炎症、脂质积累和糖异生相关的途径和关键调节因子。结论THF通过激活CRLS1-ATF3/ChREBP通路改善T2DM小鼠的脂质分布,减轻肝脏脂肪变性。
{"title":"Tianhuang formula ameliorates non-alcoholic fatty liver diseases in type 2 diabetic mice through CRLS1-ATF3/ChREBP pathway","authors":"Yi Han ,&nbsp;Yating Zhao ,&nbsp;Xuefeng Xu ,&nbsp;Zhizhong Luo ,&nbsp;Duosheng Luo ,&nbsp;Jiao Guo","doi":"10.1016/j.jhip.2023.09.002","DOIUrl":"https://doi.org/10.1016/j.jhip.2023.09.002","url":null,"abstract":"<div><h3>Objective</h3><p>Tianhuang Formula (THF) is a hospital formula summarized by Professor Jiao Guo's 30 years of clinical experience. Some studies have shown that it can alleviate dyslipidemia in the body. The purpose of this study is to confirm whether THF can improve non-alcoholic fatty liver diseases (NAFLD) in type 2 diabetic mice induced by high-fat diet (HFD)/streptomycin (STZ) and to clarify its potential mechanism.</p></div><div><h3>Methods</h3><p>After induction of diabetes, mice were administrated with THF (60 ​mg/kg or 120 ​mg/kg) once daily for 10 weeks. Blood glucose (FBG), glucose tolerance, and insulin resistance (IR) were assayed by oral glucose tolerance test (OGTT) and insulin tolerance test (ITT). Blood lipids, alanine transaminase (ALT), and aspartate transaminases (AST) were detected. Serum fasting insulin (INS) and adiponectin (APN) levels were measured using ELISA. Histological changes in liver and pancreatic islets were observed by H&amp;E staining, followed by Oil Red O staining for liver lipid quantification and periodic acid-Schiff (PAS) staining to detect glycogen accumulation. Western blotting detected the levels of fatty cardiolipin synthase 1 (CRLS1), transcription factor activator 3 (ATF3), and carbohydrate-responsive element binding protein (ChREBP) in the liver. The mRNA transcripts of hepatic inflammatory factors, lipogenesis and lipolysis-related genes, and gluconeogenic enzyme-phosphoenolpyruvate carboxykinase (PEPCK), CRLS1, ATF3, and ChREBP mRNA levels were evaluated by RT-qPCR.</p></div><div><h3>Results</h3><p>THF restored impaired glucose tolerance and insulin resistance, respectively. There was an improvement in HFD/STZ-induced liver and islet damage, high serum HDL-C and ANP levels, and a significant decrease in FBG, total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), FFA, INS, ALT, and AST, and lipid droplet counts in the T2DM mice treated with THF. CREBBP binding protein ATF3 mediated the insulin resistance signaling pathway, which regulated glucose and lipid metabolism in the liver. THF upregulated CRLS1, and ChREBP downregulated the expression of downstream ATF3 in the liver. RT-qPCR analysis also systemically indicated that THF suppressed the pathway and key regulators related to inflammation, lipid accumulation, and gluconeogenesis.</p></div><div><h3>Conclusion</h3><p>Our findings demonstrated that THF ameliorated lipid profile and attenuated liver steatosis in T2DM mice through CRLS1-ATF3/ChREBP pathway activation.</p></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"4 2","pages":"Pages 147-156"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2707368823000857/pdfft?md5=7d230b18bbe01d2bb10e3b948adee93b&pid=1-s2.0-S2707368823000857-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92047820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Holistic Integrative Pharmacy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1